TCL Archive White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87 March 6, 1987
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: NIEHS to Observe20th Anniversary Dec. 3-5 With Scientific Presentations, Big Celebration November 21, 1986
TCL Archive HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report July 10, 1998
TCL Archive Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill June 14, 1974
